News

Eli Lilly (NYSE: LLY) was an unstoppable bet in the past few years, but LLY stock finally started plateauing in the latter ...
The president said his executive order will require pharmaceutical companies to price drugs in the U.S. in line with the ...
US President Donald Trump has signed an executive order that aims to reduce high prescription drug prices – but its details ...
The U.S. imports more pharmaceutical products from Ireland than from any other country -- nearly $50 billion last year. It won't be surprising if the Trump administration especially targets those ...
Novo Nordisk’s new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...
The county joins municipalities across the country suing Eli Lilly, CVS Caremark, and others for sky-high prices.
Pharmaceutical companies are making billions on treatments that can sometimes overpromise and underdeliver for terminal cases ...
Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity for patients who have to pay for the drug themselves. It said it will ...
This proves that Eli Lilly's obesity drug Zepbound, as a GLP-1/GIP agonist ... could benefit from any potential gains made here. In order for patients to be recruited into this specific study ...
The order aims to slash drug prices by up to 80%. Indian industry had been on edge since March amid threats of reciprocal ...